Information on this site is provided for informational purposes and is not meant to substitute for the advice provided by your own physician or other medical professional. You should not use the information contained herein for diagnosing or treating a health problem or disease, or prescribing any medication. Information about each product is taken from user comments, the labels of the products or from the manufacturer's advertising material. RxCoup is not responsible for any statements or claims that various manufacturers make about their products. We cannot be held responsible for typographical errors or product formulation changes. You should read carefully all product packaging. If you have or suspect that you have a medical problem, promptly contact your health care provider. Information and statements regarding dietary supplements have not been evaluated by the Food and Drug Administration and are not intended to diagnose, treat, cure, or prevent any disease. All discounts are taken from suggested retail prices, are not intended to act as or replace insurance, and are subject to change.

According to the FDA’s definition of “bio-equivalent “A generic's maximum concentration of active ingredient in the blood must not fall more than 20% below or 25% above that of the brand name.”(See Case Studies 1, 2, 3 and 4)

This means a potential range of 45%; yet generics labeled same as brands

Due to an unprecedented patent cliff, on average brands lose 70% of sales to generics in the 12 months immediately proceeding loss of exclusivity (LOE). Lost sales of $250 Billion/year to generics come at a time when the medicine efficacy of generics are being called into question by scientists and healthcare Providers.

Solution:

RxCoup gives brands an opportunity to use mobile Rx co-pay coupons to immediately lower patients’upfront out-of-pocket costs to within range of the price of generics, while maintaining the medicine efficacy/safety of the original brand formula. (See Case Study 6)

Personalized medicine is the use of genomic information - in addition to family history, lifestyle, and environmental factors - to customize health management. By combining genomic and clinical information, more accurate predictions can be made about a person’s susceptibility of developing disease, the course of disease, and response to treatment. (See Case Studies 4 and 5)